Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (441-450 of 555) with videos related to

Pageof 56
Sort By:
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
BMC Cancer|February 7, 2020
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumorsCésar Serrano, Ana Vivancos, Antonio López-Pousa, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Prognostic Accuracy of N20 Somatosensory Potential in Patients With Acute Ischemic Stroke and Endovascular ThrombectomyAlicia Martinez-Piñeiro, Giuseppe Lucente, María Hernandez-Perez, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Frontiers in Public Health|March 13, 2023
Monitoring residues of pesticides in food in Brazil: A multiscale analysis of the main contaminants, dietary cancer risk estimative and mechanisms associatedJuliana Maria Bitencourt de Morais Valentim, Tatiane Renata Fagundes, Mariane Okamoto Ferreira, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Clinical Sarcoma Research|July 1, 2016
Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 studyJoan Maurel, Antonio López-Pousa, Silvia Calabuig, et al.
Cancers|May 6, 2020
<i>CUL4A</i>, <i>ERCC5</i>, and <i>ERCC1</i> as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) StudyDavid S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, et al.
Pageof 56

Showing results (441-450 of 555) with videos related to

Sort By:
Pageof 56
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
BMC Cancer|February 7, 2020
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumorsCésar Serrano, Ana Vivancos, Antonio López-Pousa, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Prognostic Accuracy of N20 Somatosensory Potential in Patients With Acute Ischemic Stroke and Endovascular ThrombectomyAlicia Martinez-Piñeiro, Giuseppe Lucente, María Hernandez-Perez, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Frontiers in Public Health|March 13, 2023
Monitoring residues of pesticides in food in Brazil: A multiscale analysis of the main contaminants, dietary cancer risk estimative and mechanisms associatedJuliana Maria Bitencourt de Morais Valentim, Tatiane Renata Fagundes, Mariane Okamoto Ferreira, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Clinical Sarcoma Research|July 1, 2016
Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 studyJoan Maurel, Antonio López-Pousa, Silvia Calabuig, et al.
Cancers|May 6, 2020
<i>CUL4A</i>, <i>ERCC5</i>, and <i>ERCC1</i> as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) StudyDavid S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, et al.
Pageof 56